Samples with high populations of NRF1+NRF2+ tumor cells displayed a significantly higher probability of survival than samples with low populations of NRF1+NRF2+ tumor cells (Figure 4, HR, 1.655; 95% CI, 1.043–2.624, * p = 0.03). Here, NFE2L2 is linked to neoplasm.